Geovax highlights progress on mpox vaccine and COVID-19 trial advancements
Source: SeekingAlpha
2025-05-01 20:59:12 ET
More on GeoVax, GeoVax Labs, Inc. WT EXP 092925, etc.
- GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript
- GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript
- WHO maintains public health emergency alert on mpox
- Seeking Alpha’s Quant Rating on GeoVax
- Historical earnings data for GeoVax
Read the full article on Seeking Alpha
For further details see:
Geovax highlights progress on mpox vaccine and COVID-19 trial advancements
GeoVax Labs Inc. Warrants
NASDAQ: GOVXW
GOVXW Trading
-57.3% G/L:
$0.0038 Last:
49,733 Volume:
$0.0065 Open:
GOVXW Latest News
GOVXW Stock Data
$4,607,511
1,728,603
N/A
6
N/A
Biotechnology & Life Sciences
Healthcare
US
Smyrna
